# A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection

> **NCT02806674** · NA · UNKNOWN · sponsor: **The University of Hong Kong-Shenzhen Hospital** · enrollment: 1845 (estimated)

## Conditions studied

- Gastritis

## Interventions

- **DEVICE:** The eradication times of the patients
- **DEVICE:** The result of 13C-urea breath test after treatment

## Key facts

- **NCT ID:** NCT02806674
- **Lead sponsor:** The University of Hong Kong-Shenzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2019-06
- **Final completion:** 2019-12
- **Target enrollment:** 1845 (ESTIMATED)
- **Last updated:** 2017-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02806674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02806674, "A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02806674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*